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Impact of adiposity on 
immunological parameters
Impacto da adiposidade nos parâmetros imunológicos
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AbstrAct
Studies evaluating immune function in obese humans and experimental animals indicate that 
the excess adiposity is associated with impaired in immune responses. Obesity is related to 
a higher rate of infections and to some types of cancer. Nutritional, metabolic and endocri-
ne factors are implicated in the immunological changes. The adipose tissue directly produces 
substances with various functions related to immune system. Furthermore, some investiga-
tions suggest that certain types of weight reduction strategies can alter the immune function. 
Nevertheless, long-term studies should be carried out to address whether these changes positi-
vely affects the ability of these obese individuals to control infections and tumor development. 
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resumo
Estudos acerca da função imunológica em animais experimentais e humanos obesos indicam 
que o excesso de adiposidade associa-se ao prejuízo da resposta imune. A obesidade está relacio-
nada a uma taxa maior de infecções e a alguns tipos de câncer. Fatores nutricionais, metabólicos e 
endócrinos estão implicados nessas alterações imunológicas. O próprio tecido adiposo produz di-
retamente substâncias com várias funções relacionadas ao sistema imune. Além disso, algumas 
investigações sugerem que certas estratégias para perda de peso podem alterar a função imune. 
Entretanto, estudos em longo prazo são necessários para avaliar se tais alterações afetam posi-
tivamente a capacidade desses pacientes obesos de controlar infecções e desenvolver tumores. 
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IntroDuctIon
Obesity is a worldwide public health problem as-sociated with several comorbidities, such as car-
diovascular diseases, diabetes, reproductive disorders, 
osteoarthritis, gallstones, respiratory disease and some 
types of cancers (1). Furthermore, obesity has also been 
associated with decreased immunocompetence (2).
The immune response has two interconnected ma-
jor branches, innate or natural immunity and acquired 
or adaptive immunity, which acts in a concerted way to 
generate protective immunity. Innate immunity includes 
physical barriers, complement system, macrophage-
monocyte system and natural killer (NK) cells. Adap-
tive immunity comprises humoral immunity, in which 
B-lymphocytes produce and secrete antigen-specific 
antibodies, and cell-mediated immunity, that relies on 
T-lymphocytes. The T-lymphocytes can be categorized, 
according to their functions and phenotype, as helper 
T (Th) lymphocytes and cytotoxic T (Tc) lymphocytes. 
Th-lymphocytes (CD4+) regulate the immune response 
by producing cytokines that activates macrophages, 
NK cells and B-lymphocytes, amplifying, in an antigen-
dependent and specific fashion, the immune response. 
Tc-lymphocytes (CD8+) produce cytokines and mediate 
cytotoxic, targeting and killing transformed or infected 
cells (3).
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Obesity can alter innate and adaptive immunity and im-
munity deterioration is related to the grade of obesity (2).
obesIty AnD Immune functIon 
relAtIonshIps
The impact of obesity in immunity has been studied 
in animal models and human subjects. Diet-induced 
obese animals, considered a comparable model for hu-
man obesity, present altered immunological parameters. 
Lamas and cols. (4,5) observed lymphopenia, lower 
splenic mitogenic response and a tendency to lower cy-
totoxic activity of NK cells in diet-induced obese rats. 
Impaired contact hypersensitivity was also observed in 
diet-induced obese mice (6).
The impact of obesity in controlling infection clear-
ance has also been assessed in animal models. Diet-in-
duced obese mice have increased mortality compared to 
lean controls when infected with influenza virus. This 
findings has been related to a substantial reduction in NK 
cell cytotoxicity and lower expression of antiviral cytok-
ines, specially type I interferons. In this study, the authors 
concluded that obesity inhibits the immune system’s abil-
ity of appropriately responding to influenza infection, and 
hypothesized that obesity can lead to increased morbidity 
and mortality due to viral infections (7). 
Impaired immune responses have also been suggested 
to occur in obese humans. Studies indicated that the in-
cidence and severity of certain infections are higher in 
obese individuals when compared to lean people (8). We-
ber and cols. (9) showed that obesity was associated with 
a poor antibody response to hepatitis B plasma vaccine. 
Obesity has also been linked to a higher incidence of 
some types of cancer. The biological mechanisms that 
link obesity to cancer seem to be multifactorial and to 
involve a group of metabolic and immunological fac-
tors. Several mechanisms by which obesity induces or 
promotes tumorigenesis have been proposed, includ-
ing insulin resistance and resultant chronic hyperinsu-
linaemia, increased bioavailability of steroid hormones 
and factors released by adipocytes, such as leptin, tu-
moral necrosis factor-α (TNF-α) and interleukin (IL)-6 
(10,11). Obesity is related to a condition of chronic 
inflammation characterized by abnormal production of 
inflammatory cytokines with local and systemic effects 
that can contribute to the development of tumors (11). 
Although local limited inflammation may be involved 
in the initiation of immune responses, excessive inflam-
mation may promote tumor progression in steady-state 
conditions (12). Chronic overproduction of reactive 
oxygen species and cytokines related to obesity by in-
flammatory cells can induce mutagenic changes and 
DNA damage, thus contributing to cancer develop-
ment (11). Finally, the pro-inflammatory cytokines can 
exacerbate the insulin resistance (10). 
Data from literature show differences in immune res-
ponse between obese and non-obese individuals. Obe-
sity is related to higher neutrophil, monocyte as well as 
total leukocyte counts (13) and to lower lymphocyte re-
sponses to mitogens (14-16). Chandra and Kutty (16) 
found lower lymphoproliferative response to mitogens, 
impairment of delayed cutaneous hypersensitivity and 
a decrease in intracellular bacterial killing capacity by 
neutrophils in obese children and adolescents. Mori-
guchi and cols. (17) proposed that the decreased lym-
phoproliferative response observed in obese rats may 
be, in part, due to decreased glucose uptake as the main 
energy source for proliferation of lymphocytes. These 
authors showed that obese rats have a decreased expres-
sion of glucose transporter 1 (GLUT-1), which is ex-
pressed on the immune cells membranes after mitogen 
stimulation. However, further investigation is needed 
to determine if this is the case in humans as well.
Few studies have evaluated specific parameters of im-
munity in patients with grade III obesity. Studies from 
the 1980’s described that severely obese individuals 
have lower maturation of monocytes into macrophages 
(18) and reduced polymorphonuclear (PMN) bacteri-
cidal capacity (19). Differences were also observed in 
surface markers expressed by monocytes, neutrophils 
and lymphocytes when patients with grade III obesity 
were compared to controls individuals with normal 
weight (20). 
ADIpose tIssue As A pro-InflAmmAtory 
orgAn
Adipose tissue has not only been recognized as a mul-
tifunctional organ, which plays an important role not 
only as an energy storage organ, but also exerting im-
portant endocrine and immune functions. Various active 
molecules released by adipocytes, such as IL-6, TNF-α, 
and leptin, may act on immune cells leading to local and 
systemic inflammation (21,22). Several lines of evidence 
suggest that preadipocytes could function as macrophag-
es-like cells, supporting the idea of a direct involvement 
of adipose tissue in inflammatory processes (23). More-
over, it has been estimated that the percentage of mac-
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rophages in adipose tissue ranges from less than 10% in 
lean mice and humans to 40 to 50% in obese humans 
(24). Inflammatory cytokines, as IL-6 and TNF-α, seem 
to be produced by the infiltrating macrophages in the 
adipose tissue (24). CC-chemokine ligand 2 (CCL2), 
produced by adipocytes, has recently been identified as a 
potential contributing factor to macrophage infiltration 
into adipose tissue (21). These events might perpetuate 
a vicious cycle of macrophage recruitment and produc-
tion of pro-inflammatory cytokines. 
The biological activities of IL-6 include the activa-
tion of immune cells and the regulation of acute-phase 
response, which involves the hepatic synthesis of inflam-
matory mediators. Furthermore, IL-6 has stimulatory 
actions on the hypothalamic-pituitary-adrenal axis, tak-
ing part as mediator of metabolic and immune respons-
es (25). IL-6 decreases lipoprotein lipase activity, in-
creasing macrophage uptake of lipids and contributing 
to the progression of atheroma plaque (25). As much 
as one third of total plasma IL-6 has been estimated to 
derive from adipose tissue (22). As IL-6 is believed to 
be the major regulator of hepatic acute phase response, 
and adipose tissue produces large amounts of this cy-
tokine, it is conceivable to hypothesize that obesity can 
resemble a low-grade inflammatory state (25). TNF-α 
has also been involved in the activation of immune re-
sponse (3). Studies indicate a role for TNF-α in obesi-
ty-linked insulin resistance, thus it seems to be involved 
in the pathogenesis of diabetes and dyslipidemia (26). 
Leptin is the most studied adipocyte-derived hormone 
and body mass index (BMI) is the main determinant of 
circulating leptin in the body (27). Its functional receptor 
is expressed not only in the hypothalamus, where it regu-
lates energy homeostasis and neuroendocrine function, 
but also in several cell types of innate and adaptive immu-
nity (28). In vitro studies using both animal and human 
cells with complete leptin deficiency have demonstrated 
the role of leptin in modulating immune function. Leptin 
can stimulate the development of myeloid cells, activate 
monocytes and macrophages, modulate dendritic cells 
and NK cells, and influence the proliferation and cytokine 
production by the T-lymphocytes with a shift toward Th1 
phenotype immune response (28). Chan and cols. (29) 
showed that the complete leptin depletion from human 
serum with anti-human leptin antibody suppresses the 
proliferative response of T-lymphocytes in vitro and that 
this phenomenon can be reverted by leptin replacement. 
Macrophages from mice lacking leptin or its func-
tional receptor have reduced phagocitic function (30). 
Furthermore, T-lymphocytes responses are impaired in 
these mice (17,31), which also present lymphoid or-
gans atrophy (32) and impaired function of dendritic 
cells (33). In cases of leptin deficiency, these alterations 
are reversible with leptin administration (30,32,33). 
Similarly, patients with obesity due to the rare congeni-
tal leptin deficiency seem to have increased the suscep-
tibility to infection (28). The administration of recom-
binant human leptin to two children with this cause of 
obesity restored the proliferative response and cytokine 
production by lymphocytes (34). 
Mito and cols. (35) observed that starvation with 
or without exogenous leptin administration has distinct 
effects on immunological parameters in diet-induced 
obese mice and lean controls. Starvation of the control 
mice dramatically reduced the weights of immune or-
gans, cytokine production and increased proliferation of 
cultured splenocytes. However, these levels returned to 
those of the free-feeding group upon exogenous leptin 
administration. The effects of exogenous leptin, on the 
other hand, were not observed in obese mice. It is pos-
sible that immune cells from obese individuals acquire 
leptin resistance, rendering them refractory to leptin 
stimulation despite its high concentration in the serum. 
A recent study showed that the stimulatory effect of 
leptin on NK cells activity is abrogated in diet-induced 
obese mice (36). It has been demonstrated that these 
animals have lower activation of post-receptor signal-
ing components following an in vivo leptin challenge. 
This study suggests that the underlying mechanism for 
leptin resistance in NK cells from obese experimental 
animals is a defect in Janus tyrosine kinase (JAK2)-
mediated activation of signal transducer and activator 
of transcription 3 (STAT3). Other authors have shown 
that STAT3-mediated signaling in T-lymphocytes is de-
creased in a diet-induced mouse model of obesity (37). 
In conclusion, these studies demonstrate that leptin re-
sistence associated to diet-induced obesity can occur not 
only at hypothalamic level, but also at immune cells. 
effects of nutrIents on Immune system 
Excess of nutrients can affect immune responses direct-
ly and indirectly, by affecting metabolic and endocrine 
status of the individual. Lymphocytes and NK cells are 
cells with high metabolism, and with extreme depen-
dency on glucose to get energy and to glycosilate their 
surface receptors (38). Moreover, these cells can be af-
fected by modified lipoprotein to secrete vasoactives 
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factors (39). Dietary lipids have an important regula-
tory action in the immune system, including modula-
tion of eicosanoid synthesis, alterations in plasma mem-
brane structure, and changes in lipoprotein metabolism 
(40). High fat intake may be harmful to lymphocytes 
function. A study showed that a diet rich in saturated fat 
impairs the response of both naive and antigen-experi-
enced T-cells (41). Barone and cols. (42) suggested that 
lowering the amount of fat in diet may improve the NK-
cell cytotoxic activity. It was observed that obese subjects 
usually have a higher fat intake (43), which can contrib-
ute to the immune dysfunction in this population.  
effects of weIght loss In the Immune 
functIon
weight loss induced by diet
It has been suggested that certain types of weight reduc-
tion strategies produce alterations in immune function. 
Diet-induced overweight rats have increased Th cells 
percentage, proliferative response of splenocytes and 
increased NK-mediated cytotoxic activity against target 
cells one month after energy restriction (5). Weight-re-
ducing diets are the most common treatment for obesity. 
Their effects on immunocompetence have been report-
ed in some studies, but the results are controversial. 
Studies have pointed out to an improvement of immu-
nological parameters after weight loss. Subjects exam-
ined after weight loss, induced by 14-days fast, showed 
improvement in serum immunoglobulin levels, de-
layed-type hypersensitivity (DTH) response, bactericid-
al capacity of blood monocytes and NK cell cytotoxic 
activity, although there was a decrease in  mitogen-stim-
ulated lymphocyte proliferation (44). Tanaka and cols. 
(14,15), on the other hand, showed that mitogen-stim-
ulated lymphocyte proliferation, which was suppressed 
in obese patients, was restored after weight loss induced 
by very low calorie diet (VLCD). The majority of the 
reports suggest that caloric restriction improves param-
eters of immunity such as T cell responses to mitogens, 
NK cell activity and the ability of mononuclear cells to 
produce pro-inflammatory cytokines (45).
In contrast, some studies have reported that weight 
loss is associated with reduction in some aspects of im-
mune function. Caloric restriction for three months 
resulted in decreased number of circulating NK cells, 
immunoglobulin (Ig) G, IgA and C3 factor of comple-
ment in a cohort of overweight women (46). Suppres-
sion of NK cell activity, without reduction of circulat-
ing NK cells, was observed in obese women submitted 
to a eight-week 950 kcal/day diet (47). Reduction in 
mitogen-stimulated lymphocyte proliferation was re-
ferred six months after VLCD (48) and after a 12-week 
moderate energetic restriction (1200-1300 kcal) (13). 
Field and cols. (48) also observed a significant decrease 
in the percentage of Th cells and a drop in the CD4+/
CD8+ ratio during VLCD. These parameters returned 
to baseline values upon refeeding. Differences in the 
assays, characteristics of subjects studied, type and du-
ration of diet employed make it difficult to compare the 
available data. 
weight loss induced by surgery
Surgical treatment is currently the most effective ther-
apy to promote and maintain weight loss in severely 
obese patients. Several bariatric procedures are available 
and the therapeutic success is variable depending on the 
employed technique. These surgeries promote weight 
loss by two main mechanisms: restriction of food intake 
and food malabsorption (49).  
Jejunoileal bypass, also called intestinal bypass, was 
a purely malabsorptive procedure employed between 
the 60’s and the 80’s. This technique induced serious 
complications such as hepatic failure, immune complex 
arthritis, nephrolithiasis and deficiency of vitamins and 
minerals, being replaced by improved ones later on. 
Two studies reported improvement in some aspects of 
immune function after this surgery. Palmblad and cols. 
(19) showed an increase in PMN bactericidal capacity 
and Hallberg and cols. (50) observed improvement in 
DTH. Nevertheless, there are reports of unusual fungal 
infections following this procedure (51).  
Restrictive procedures, such as vertical banded gas-
troplasty (VBG) and adjustable gastric banding (AGB), 
promote weight loss by physical restriction of food in-
take and induction of satiety. Studies described a de-
crease in PMN and lymphocytes counts following AGB 
(52,53). Decrease in acute phase proteins was observed 
six months after AGB (52). Through another study, van 
Dielen and cols. (54) showed that soluble TNF receptors 
and acute phase proteins remained elevated for at least 
six months after gastric restrictive surgery, decreasing sig-
nificantly 24 months after the intervention. Reduction of 
IL-3 and TNF-α serum levels were observed six months 
after weight loss induced by VBG (55). 
Higher rates of successful weight loss are obtained 
with combined procedures that consist in decreasing the 
Impact of adiposity on immunological parameters
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gastric capacity associated with gastroenteric bypass. The 
Roux-en-Y gastric bypass (RYGB) is currently the most 
commonly performed bariatric surgery, and it appears to 
be more effective in inducing and maintaining a satisfac-
tory weight loss, with lower rates of complications (49).
The majority of studies addressing the effect of bar-
iatric surgery on immune function have focused on in-
flammation markers. A recent study with ten women 
that underwent biliopancreatic bypass observed, 36 
months after surgey, a decline in reactive C protein 
(RCP), IL-6 and α-defensins levels, with no difference 
in TNF-α levels (56). McAuliffe and cols. (57) ob-
served an increase in blood monocytes and a reduction 
in circulating dentritic cells until 28 days after RYGB. 
Vilarrasa and cols. (58) found decreased IL-18, TNF-α 
receptors and RCP serum levels one year after gastric 
bypass. The group of Cottam (20) found higher ex-
pression of CD95 per T cell, a molecule involved in 
induction of apoptosis, and lower CD62L (L-selectin) 
expression, in severely obese patients when compared 
to controls with ideal weight, and reduction and in-
crease, respectively, of these cellular markers one year 
after RYGB. The decreased levels of L-selectin might 
impair migration and recirculation of lymphocytes. 
Cottam and cols. (20) did not observed any modifi-
cations in cell populations of B, T and NK cells until 
one year after surgery. In another study, the effects 
of excessive adiposity and weight loss on macrophage 
chemoattractant protein-1 (MCP-1) and interferon 
(IFN)-γ, which are important components of immune 
response to infectious pathogens, production by PBMC 
were evaluated in severely obese patients before and one 
year after RYGB. It was observed that the concentration 
of these molecules, which were lower in obese patients 
than in age-matched lean subjects, were restored after 
weight loss induced by surgery (59). 
Our group addressed the functional status of NK 
cells before and six months after RYGB. We demon-
strated that in 28 patients with grade III obesity, NK 
cell activity is enhanced six months after the surgery, 
when the patients had lost in average 26% of initial 
weight. We have also shown that severely obese pa-
tients have a significant decrease in NK cells activity in 
comparison to normal individuals matched for age and 
gender. This decrease could not be subscribed to a de-
crease in the numbers of circulating NK cells since the 
individual numbers as well as the averages were similar, 
prior to and six months after surgery. Furthermore, we 
found that the PBMC production of cytokines involved 
in modulating NK cells activity, as IL-12, IL-18 and 
IFN-γ (60), increased significantly after surgery, which 
suggests a link between these two parameters (NK cells 
activity and specific cytokine modulation) (Moulin and 
cols., unpublished data).
Natural killer (NK) cells are innate immunity cells 
involved in the control of cancer and infections (3). 
Although we have not studied the clinical outcomes 
but rather the effect of obesity on the functional sta-
tus of NK cells, it is important to notice the correla-
tion between low NK cytotoxic activity, and a higher 
incidence of tumors and infections in obese subjects. 
Therefore, we propose that the impaired NK cells cy-
totoxic activity and cytokines production observed in 
patients with severe obesity can be one mechanism 
involved in their propensity to developing cancer and 
infections. Our data also showed that the functional 
status of NK cells can be restored upon weight loss, 
demonstrating that the weight loss induced by bar-
iatric surgery can positively and significantly impact 
these factors. However, long-term studies should be 
performed to address whether these changes positively 
affects the ability of these subjects to control infections 
and tumor development. 
conclusIons
Obesity is associated with the impairment of immune 
response. Epidemiological data indicate a higher sus-
ceptibility of obese individuals to infectious diseases and 
cancer. Therefore, it is conceivable that obesity alters im-
munity culminating in secondary diseases. Furthermore, 
many obese patients have alterations of glycidic and lip-
idic metabolism, which can impair lymphocytes and NK 
cells function. Finally, the adipose tissue, besides being 
an endocrine organ, produces substances with various 
functions that are related to immune system.  
The exact mechanism responsible for alterations in 
the immune system of obese patients is unknown, but 
can be related to the negative effects of altered nutri-
tional, metabolic, endocrine, and psychological status 
on immune cells function. Weight reduction has a pro-
found effect on many of these variables. Probably, the 
improvement of the physiological milieu contributes to 
an amelioration of immune function after weight loss.   
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